About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

The World's First Therapeutic WNV(West Nile Virus) Vaccine Will be Ready for Market

by Hannah Punitha on November 5, 2008 at 8:19 PM
Font : A-A+

 The World's First Therapeutic WNV(West Nile Virus) Vaccine Will be Ready for Market

Researchers at the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig are developing a DNA-based vaccine against the dreaded West Nile virus (WNV), which can be transmitted from animals to humans.

The special feature of this vaccine is that it is also effective after onset of the disease, for it has therapeutic properties.

Advertisement

"In this type of vaccine, DNA molecules known as plasmids extracted from the pathogen are used for inoculation, instead of the whole virus. They contain the genetic code for the antigens that stimulate the body to produce antibodies. We can thus replicate the virus's natural infection route without actually triggering the disease," said Dr. Matthias Giese, the IZI's head of vaccine development.

Traditional methods of vaccination involve injecting a dead or weakened form of the pathogen into the patient's body, which responds by producing the corresponding antibodies and developing immunity to the disease.
Advertisement

An alternative is to inject a serum that already contains these antibodies. Such vaccines are merely preventive.

By contrast with live vaccines, which carry a risk of provoking the disease, DNA vaccines are absolutely biologically safe.

Moreover, they activate all existing defence mechanisms in the body, are cheap to produce and can be stored without a refrigerator - which makes them ideal for use in subtropical and tropical climates.

"Since the human immune system is very similar to that of other mammals, we are developing a cross-species vaccine for use in both veterinary and human medicine. And unlike conventional vaccines, DNA vaccines can be used both as prophylactics and as therapeutics, i.e. in cases where the disease is already present," said Dr. Matthias Giese, citing the further benefits.

The WNV vaccine has already passed initial tests. Giese expects the laboratory research to be completed by the end of 2009.

After that, another 3 years or so will be needed for the approval procedure including clinical trials.

Then, it is hoped, the world's first therapeutic WNV vaccine will be ready for market.

Source: ANI
SPH
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Top 10 Vaccine Myths Debunked 

Recommended Reading
Flu Vaccines Do Protect Children from Respiratory Virus
A new study conducted by researchers at the University of Rochester Medical Center has shown that .....
Experimental HIV Vaccine Trials at Merck and Co. Caused More Infections
Trials of a once-promising experimental HIV vaccine were cut short in 2007 because the drug may ......
Study Says Vaccinating Family may Help Protect Newborns Against Flu
Vaccinating new mothers and other family members against influenza can protect newborns against the ...
Top 10 Vaccine Myths Debunked
Childhood vaccination has saved many lives, yet lots more has to be done to increase awareness and e...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use